Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-025-04149-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Silvia Zaninelli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center of Cellular Therapy "G. Lanzani", Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Cytokine-Induced Killer Cells, Tenascin, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana Ricerca contro il Cancro (AIRC), Fondazione AIRC per la ricerca sul cancro ETS, Fondazione Regionale per la Ricerca Biomedica.
Abstract (Originalsprache)
To generate CARCIK cells with enhanced targeting and penetration of solid tumors, we have designed new CAR molecules against tenascin C (TNC), an extracellular matrix and surface molecule, overexpressed in several tumor types. Two different anti-TNC CAR constructs were generated, sharing the anti-TNC scFv domain, fused to the CD3ζ fragment, but differing in co-signaling domains: CAR-TNC4 carrying the 4-1BB and CAR-TNC5 the CD28 and OX40 domains. Both CARs were introduced into cytokine-induced killer cells (CIK) by co-transfection with the sleeping beauty transposase plasmid. CARCIK-TNC cells were cytotoxic against TNC + targets, proliferated and secreted the IFN-γ and IL-2 cytokines in response to target cell binding, with overall higher efficacy of CARCIK-TNC5 compared to CARCIK-TNC4. To enhance activity and specificity, we also generated a dual construct, carrying a secretable EGFRxCD3 bispecific T cell engager (sBiTE) antibody cDNA. CIK transfected with EGFRxCD3/CAR-TNC5 showed good expression of both molecules and synergistic killing of MDA-MB-231 cells in vitro compared to cells transfected with the single-targeting molecules. Also in vivo, in the subcutaneous TNC + EGFR + MDA-MB-231 xenograft model, significantly enhanced control of tumor growth was observed after injection of CIK cells transfected with dual, compared to single constructs. We conclude that CAR-TNC5 combined with EGFRxCD3 can endow CIK cells with different and potentially synergistic functions in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Cellular Therapy "G. Lanzani", Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.
- University of Milano-Bicocca, Milan, Italy.
- Laboratory of Cancer Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- Pathology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24100, Bergamo, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Förderung
- Associazione Italiana Ricerca contro il Cancro (AIRC)
- Fondazione AIRC per la ricerca sul cancro ETS
- Fondazione Regionale per la Ricerca Biomedica
Zitieren
APA
Zaninelli, S., Cattaneo, I., Valgardsdottir, R., Frapolli, R., Bello, E., Meroni, M., Gianatti, A., Panna, S., Rizzo, P., Tomasoni, S., D'Incalci, M., Introna, M., Golay, J., & Rambaldi, A. (2025). Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04149-2
Vancouver
Zaninelli S, Cattaneo I, Valgardsdottir R, Frapolli R, Bello E, Meroni M, et al. Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04149-2
BibTeX
@article{Zaninelli2025,
author = {Zaninelli, Silvia and Cattaneo, Irene and Valgardsdottir, Rut and Frapolli, Roberta and Bello, Ezia and Meroni, Marina and Gianatti, Andrea and Panna, Silvia and Rizzo, Paola and Tomasoni, Susanna and D'Incalci, Maurizio and Introna, Martino and Golay, Josée and Rambaldi, Alessandro},
title = {Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-025-04149-2}
}
EUVIMED